Tyra Biosciences, Inc. cotiza a 19.60 USD y tiene una capitalización bursátil de $1.3B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.69 | $-0.64 | $-0.57 |
| Estimado | $-0.66 | $-0.64 | $-0.59 | $-0.53 |
| Sorpresa | — | -7.8% | -8.5% | -7.5% |
| Métrica | TYRA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -46.3% | -40.4% | -5.9% |
| ROA | -42.4% | -32.0% | -10.4% |
| Current Ratio | 14.67 | 2.84 | +11.83 |
| Debt / Equity | — | 0.28 | — |